254 related articles for article (PubMed ID: 26508020)
1. Potential involvement of NET polymorphism in serotonin/norepinephrine reuptake inhibitor response in panic disorder.
Park HJ; Kim SK; Kang WS; Kim YJ; Cho AR; Park JK
Nord J Psychiatry; 2016; 70(4):314-7. PubMed ID: 26508020
[TBL] [Abstract][Full Text] [Related]
2. Monoamine transporter gene polymorphisms affect susceptibility to depression and predict antidepressant response.
Min W; Li T; Ma X; Li Z; Yu T; Gao D; Zhang B; Yun Y; Sun X
Psychopharmacology (Berl); 2009 Aug; 205(3):409-17. PubMed ID: 19468717
[TBL] [Abstract][Full Text] [Related]
3. Monoamine transporter gene polymorphisms and antidepressant response in koreans with late-life depression.
Kim H; Lim SW; Kim S; Kim JW; Chang YH; Carroll BJ; Kim DK
JAMA; 2006 Oct; 296(13):1609-18. PubMed ID: 17018806
[TBL] [Abstract][Full Text] [Related]
4. SERT and NET polymorphisms, temperament and antidepressant response.
Andre K; Kampman O; Illi A; Viikki M; Setälä-Soikkeli E; Mononen N; Lehtimäki T; Haraldsson S; Koivisto PA; Leinonen E
Nord J Psychiatry; 2015; 69(7):531-8. PubMed ID: 25739526
[TBL] [Abstract][Full Text] [Related]
5. Comparison of adjunctive use of aripiprazole with bupropion or selective serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors: analysis of patients beginning adjunctive treatment in a 52-week, open-label study.
Clayton AH; Baker RA; Sheehan JJ; Cain ZJ; Forbes RA; Marler SV; Marcus R; Berman RM; Thase ME
BMC Res Notes; 2014 Jul; 7():459. PubMed ID: 25037144
[TBL] [Abstract][Full Text] [Related]
6. Polymorphism of rs3813034 in Serotonin Transporter Gene SLC6A4 Is Associated With the Selective Serotonin and Serotonin-Norepinephrine Reuptake Inhibitor Response in Depressive Disorder: Sequencing Analysis of SLC6A4.
Nonen S; Kato M; Takekita Y; Wakeno M; Sakai S; Serretti A; Kinoshita T
J Clin Psychopharmacol; 2016 Feb; 36(1):27-31. PubMed ID: 26674707
[TBL] [Abstract][Full Text] [Related]
7. Early response to selective serotonin reuptake inhibitors in panic disorder is associated with a functional 5-HT1A receptor gene polymorphism.
Yevtushenko OO; Oros MM; Reynolds GP
J Affect Disord; 2010 Jun; 123(1-3):308-11. PubMed ID: 19800133
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic-Pharmacodynamic interaction associated with venlafaxine-XR remission in patients with major depressive disorder with history of citalopram / escitalopram treatment failure.
Ahmed AT; Biernacka JM; Jenkins G; Rush AJ; Shinozaki G; Veldic M; Kung S; Bobo WV; Hall-Flavin DK; Weinshilboum RM; Wang L; Frye MA
J Affect Disord; 2019 Mar; 246():62-68. PubMed ID: 30578947
[TBL] [Abstract][Full Text] [Related]
9. Serotonin transporter polymorphism and bleeding time during SSRI therapy.
Hougardy DM; Egberts TC; van der Graaf F; Brenninkmeijer VJ; Derijks LJ
Br J Clin Pharmacol; 2008 May; 65(5):761-6. PubMed ID: 18279474
[TBL] [Abstract][Full Text] [Related]
10. Increased brain serotonin turnover in panic disorder patients in the absence of a panic attack: reduction by a selective serotonin reuptake inhibitor.
Esler M; Lambert E; Alvarenga M; Socratous F; Richards J; Barton D; Pier C; Brenchley C; Dawood T; Hastings J; Guo L; Haikerwal D; Kaye D; Jennings G; Kalff V; Kelly M; Wiesner G; Lambert G
Stress; 2007 Aug; 10(3):295-304. PubMed ID: 17613943
[TBL] [Abstract][Full Text] [Related]
11. The influence of 5-HTTLPR and STin2 polymorphisms in the serotonin transporter gene on treatment effect of selective serotonin reuptake inhibitors in depressive patients.
Smits KM; Smits LJ; Peeters FP; Schouten JS; Janssen RG; Smeets HJ; van Os J; Prins MH
Psychiatr Genet; 2008 Aug; 18(4):184-90. PubMed ID: 18628680
[TBL] [Abstract][Full Text] [Related]
12. [Prediction of antidepressant response to milnacipran and fluvoxamine using pharmacogenetical methods].
Higuchi H
Nihon Shinkei Seishin Yakurigaku Zasshi; 2010 Apr; 30(2):71-6. PubMed ID: 20491280
[TBL] [Abstract][Full Text] [Related]
13. Role of serotonin and norepinephrine transporters in antidepressant-induced arterial hypertension: a pharmacoepidemiological-pharmacodynamic study.
Montastruc JL; Rousseau V; de Canecaude C; Roussin A; Montastruc F
Eur J Clin Pharmacol; 2020 Sep; 76(9):1321-1327. PubMed ID: 32483650
[TBL] [Abstract][Full Text] [Related]
14. Antidepressants for Depression, Apathy, and Gait Instability in Parkinson's Disease: A Multicenter Randomized Study.
Takahashi M; Tabu H; Ozaki A; Hamano T; Takeshima T;
Intern Med; 2019 Feb; 58(3):361-368. PubMed ID: 30146591
[TBL] [Abstract][Full Text] [Related]
15. Time to response in panic disorder in a naturalistic setting: combination therapy with alprazolam orally disintegrating tablets and serotonin reuptake inhibitors compared to serotonin reuptake inhibitors alone.
Katzelnick DJ; Saidi J; Vanelli MR; Jefferson JW; Harper JM; McCrary KE
Psychiatry (Edgmont); 2006 Dec; 3(12):39-49. PubMed ID: 20877555
[TBL] [Abstract][Full Text] [Related]
16. Selective Serotonin Reuptake Inhibitors and Serotonin-Norepinephrine Reuptake Inhibitors Are Not Associated With Bleeding or Transfusion in Cardiac Surgical Patients.
Smith MM; Smith BB; Lahr BD; Nuttall GA; Mauermann WJ; Weister TJ; Dearani JA; Barbara DW
Anesth Analg; 2018 Jun; 126(6):1859-1866. PubMed ID: 29210786
[TBL] [Abstract][Full Text] [Related]
17. Pharmacogenetics of selective serotonin reuptake inhibitors (SSRI): A serotonin reuptake transporter (SERT)-based approach.
Sreeja V; Jose A; Patel S; Menon B; Athira KV; Chakravarty S
Neurochem Int; 2024 Feb; 173():105672. PubMed ID: 38157886
[TBL] [Abstract][Full Text] [Related]
18. Prediction of antidepressant response to milnacipran by norepinephrine transporter gene polymorphisms.
Yoshida K; Takahashi H; Higuchi H; Kamata M; Ito K; Sato K; Naito S; Shimizu T; Itoh K; Inoue K; Suzuki T; Nemeroff CB
Am J Psychiatry; 2004 Sep; 161(9):1575-80. PubMed ID: 15337646
[TBL] [Abstract][Full Text] [Related]
19. Determinants of pharmacodynamic trajectory of the therapeutic response to paroxetine in Japanese patients with panic disorder.
Ishiguro S; Watanabe T; Ueda M; Saeki Y; Hayashi Y; Akiyama K; Saito A; Kato K; Inoue Y; Shimoda K
Eur J Clin Pharmacol; 2011 Dec; 67(12):1213-21. PubMed ID: 21688171
[TBL] [Abstract][Full Text] [Related]
20. Norepinephrine and serotonin transporter genes: impact on treatment response in depression.
Baffa A; Hohoff C; Baune BT; Müller-Tidow C; Tidow N; Freitag C; Zwanzger P; Deckert J; Arolt V; Domschke K
Neuropsychobiology; 2010; 62(2):121-31. PubMed ID: 20588071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
